159 related articles for article (PubMed ID: 32933098)
1. Relative and Absolute Quantification of Aberrant and Normal Splice Variants in
Patsali P; Papasavva P; Christou S; Sitarou M; Antoniou MN; Lederer CW; Kleanthous M
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32933098
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Mono- and Bi-Functional GLOBE-Based Vectors for Therapy of β-Thalassemia by
Koniali L; Flouri C; Kostopoulou MI; Papaioannou NY; Papasavva PL; Naiisseh B; Stephanou C; Demetriadou A; Sitarou M; Christou S; Antoniou MN; Kleanthous M; Patsali P; Lederer CW
Cells; 2023 Dec; 12(24):. PubMed ID: 38132168
[TBL] [Abstract][Full Text] [Related]
3. Splice Acceptor Mutation [
Waye JS; Hanna M; Nakamura L; Walker L; Eng B; Nfonsam LE
Hemoglobin; 2024 Mar; 48(2):116-117. PubMed ID: 38360540
[TBL] [Abstract][Full Text] [Related]
4. Humanized beta-thalassemia mouse model containing the common IVSI-110 splicing mutation.
Vadolas J; Nefedov M; Wardan H; Mansooriderakshan S; Voullaire L; Jamsai D; Williamson R; Ioannou PA
J Biol Chem; 2006 Mar; 281(11):7399-405. PubMed ID: 16421096
[TBL] [Abstract][Full Text] [Related]
5. Short-hairpin RNA against aberrant
Patsali P; Papasavva P; Stephanou C; Christou S; Sitarou M; Antoniou MN; Lederer CW; Kleanthous M
Haematologica; 2018 Sep; 103(9):e419-e423. PubMed ID: 29700171
[No Abstract] [Full Text] [Related]
6. Generation and Characterization of a Transgenic Mouse Carrying a Functional Human β -Globin Gene with the IVSI-6 Thalassemia Mutation.
Breveglieri G; Mancini I; Bianchi N; Lampronti I; Salvatori F; Fabbri E; Zuccato C; Cosenza LC; Montagner G; Borgatti M; Altruda F; Fagoonee S; Carandina G; Rubini M; Aiello V; Breda L; Rivella S; Gambari R; Finotti A
Biomed Res Int; 2015; 2015():687635. PubMed ID: 26097845
[TBL] [Abstract][Full Text] [Related]
7. The Spectrum of
Bazazzadegan N; Abedini SS; Azarkeivan A; Banihashemi S; Nikzat N; Najmabadi H; Neishabury M
Hemoglobin; 2023 Nov; 47(4):147-151. PubMed ID: 37548174
[TBL] [Abstract][Full Text] [Related]
8. Amelioration of beta654-thalassemia in mouse model with the knockdown of aberrantly spliced beta-globin mRNA.
Xie S; Li W; Ren Z; Zhang J; Guo X; Wang S; Huang S; Zeng F; Zeng YT
J Genet Genomics; 2008 Oct; 35(10):595-601. PubMed ID: 18937916
[TBL] [Abstract][Full Text] [Related]
9. Detection of HBB:c.92+5G>C and HBB:c.108delC mutations in β-thalassemia carriers using high-resolution melting analysis.
Hidayati NI; Wijayanti N; Handayani NSN
Mol Biol Rep; 2020 Jul; 47(7):5665-5671. PubMed ID: 32638316
[TBL] [Abstract][Full Text] [Related]
10. Generation of an in vitro model of β-thalassemia using the CRISPR/Cas9 genome editing system.
Ajami M; Atashi A; Kaviani S; Kiani J; Soleimani M
J Cell Biochem; 2020 Feb; 121(2):1420-1430. PubMed ID: 31596028
[TBL] [Abstract][Full Text] [Related]
11. First Detection of a Splice Site β-Thalassemia Mutation, IVS-I-6 (T > C) (HBB: c.92 + 6T > C) in a Chinese Family.
Chen B; Huang P; Yi S; Chen Q; Tang Y; Zhang Q; He S
Hemoglobin; 2015; 39(3):207-8. PubMed ID: 25856402
[TBL] [Abstract][Full Text] [Related]
12. β-Thalassemia due to intronic LINE-1 insertion in the β-globin gene (HBB): molecular mechanisms underlying reduced transcript levels of the β-globin(L1) allele.
Lanikova L; Kucerova J; Indrak K; Divoka M; Issa JP; Papayannopoulou T; Prchal JT; Divoky V
Hum Mutat; 2013 Oct; 34(10):1361-5. PubMed ID: 23878091
[TBL] [Abstract][Full Text] [Related]
13. Ten Years of Routine α- and β-Globin Gene Sequencing in UK Hemoglobinopathy Referrals Reveals 60 Novel Mutations.
Henderson SJ; Timbs AT; McCarthy J; Gallienne AE; Proven M; Rugless MJ; Lopez H; Eglinton J; Dziedzic D; Beardsall M; Khalil MS; Old JM
Hemoglobin; 2016; 40(2):75-84. PubMed ID: 26635043
[TBL] [Abstract][Full Text] [Related]
14. Association between Different Polymorphic Markers and β-Thalassemia Intermedia in Central Iran.
Sajadpour Z; Amini-Farsani Z; Motovali-Bashi M; Yadollahi M; Khosravi-Farsani N
Hemoglobin; 2020 Jan; 44(1):27-30. PubMed ID: 31899996
[TBL] [Abstract][Full Text] [Related]
15. Molecular analysis of β-thalassemia patients: first identification of mutations HBB:c.93-2A>G and HBB:c.114G>A in Brazil.
Fernandes AC; Shimmoto MM; Furuzawa GK; Vicari P; Figueiredo MS
Hemoglobin; 2011; 35(4):358-66. PubMed ID: 21797703
[TBL] [Abstract][Full Text] [Related]
16. Multiplex Minisequencing of the HBB Gene: A Rapid Strategy to Confirm the Most Frequent β-Thalassemia Mutations in the Tunisian Population.
Ben Charfeddine I; Ben Lazreg T; M'sakni A; Amara A; Mlika A; Chaïeb A; Hlel K; Zouari N; Zbidi F; Bouguila J; Soyah N; Ayedi A; Ben Hamouda H; Abroug S; Boughamoura L; Saad A; Gribaa M
Hemoglobin; 2015; 39(4):251-5. PubMed ID: 26016902
[TBL] [Abstract][Full Text] [Related]
17. Hb Knossos (HBB: c.82G > T), β-globin CD 5 (-CT) (HBB: c.17_18delCT) and δ-globin CD 59 (-a) (HBD: c.179delA) mutations in a Syrian patient with β-thalassemia intermedia.
Moassas F; Nweder MS; Murad H
BMC Pediatr; 2019 Feb; 19(1):61. PubMed ID: 30777047
[TBL] [Abstract][Full Text] [Related]
18. The Spectrum of β-Thalassemia Mutations in Hamadan Province, West Iran.
Alibakhshi R; Moradi K; Aznab M; Azimi A; Shafieenia S; Biglari M
Hemoglobin; 2019 Jan; 43(1):18-22. PubMed ID: 31096791
[TBL] [Abstract][Full Text] [Related]
19. A Universal Approach to Correct Various HBB Gene Mutations in Human Stem Cells for Gene Therapy of Beta-Thalassemia and Sickle Cell Disease.
Cai L; Bai H; Mahairaki V; Gao Y; He C; Wen Y; Jin YC; Wang Y; Pan RL; Qasba A; Ye Z; Cheng L
Stem Cells Transl Med; 2018 Jan; 7(1):87-97. PubMed ID: 29164808
[TBL] [Abstract][Full Text] [Related]
20. Mutation Spectrum of β-Globin Gene in Patients with β-Thalassemia at Tidar Hospital, Magelang, Central Java, Indonesia.
'Ulya NM; Indrawati VN; Wulansari WT; Lesmana I; Handayani NSN
Hemoglobin; 2023 Nov; 47(4):152-156. PubMed ID: 37605561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
